Text Size
12 studies found for:    "Angiofollicular lymph hyperplasia"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Tocilizumab for KSHV-Associated Multicentric Castleman Disease
Conditions: Castleman Disease;   Castleman's Disease;   Giant Lymph Node Hyperplasia
Interventions: Drug: Zidovudine;   Drug: Tocilizumab;   Drug: Valganciclovir
2 Completed A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease
Conditions: Lymphoma, Non-Hodgkin;   Multiple Myeloma;   Giant Lymph Node Hyperplasia
Intervention: Drug: CNTO 328
3 Terminated Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
Conditions: HIV Infections;   Giant Lymph Node Hyperplasia
Intervention: Drug: Rituximab
4 Recruiting Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman's Disease With Correlates of Disease Activity
Condition: Giant Lymph Node Hyperplasia
Intervention:
5 Recruiting A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease
Condition: Multicentric Castleman's Disease
Intervention: Drug: Siltuximab
6 Active, not recruiting A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease
Condition: Multicentric Castleman's Disease
Interventions: Drug: CNTO 328;   Drug: Placebo
7 Withdrawn Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease
Condition: Giant Lymph Node Hyperplasia
Intervention: Drug: Valganciclovir
8 Completed A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment
Condition: Castleman's Disease
Intervention: Drug: tocilizumab [RoActemra/Actemra]
9 Recruiting Dose-escalation Study of Oral CX-4945
Conditions: Advanced Solid Tumors;   Breast Cancer;   Inflammatory Breast Cancer;   Castleman's Disease;   Multiple Myeloma
Intervention: Drug: CX-4945 oral formulation
10 Completed Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Intervention: Drug: suramin
11 Completed 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Nonneoplastic Condition;   Precancerous Condition
Intervention: Drug: tanespimycin
12 Recruiting Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
Conditions: Aids-related Malignancies;   Lymphoma;   Precancerous Condition;   Sarcoma
Interventions: Genetic: polymerase chain reaction;   Other: cytology specimen collection procedure;   Other: histological technique;   Procedure: colposcopic biopsy
To Top

† Indicates status has not been verified in more than two years